Initial Price Applicability Year 2028 Public Engagement Events

As part of the Medicare Drug Price Negotiation Program, CMS hosts public engagement events which provide an opportunity for patients, caregivers, clinicians, and others to share their experience relevant to the drugs selected for negotiation and renegotiation. 

In an effort to engage with stakeholders and incorporate their perspectives into the negotiations, CMS seeks the public’s input relevant to the selected drugs, the condition(s) that the selected drug may be used to treat, and other medications that may be used to manage those conditions. This includes information related to the clinical benefits of the selected drugs compared to therapeutic alternatives, how the selected drugs address unmet needs, and how the selected drugs impact specific populations.